Related Experiment Video

Updated: Jul 17, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering

N Hiroi1, A Funahashi, H Kitano

  • 1ERATO-SORST, Kitano Symbiotic Systems Project, Japan Science and Technology Agency, Shibuya-ku, Tokyo. nhiroi@symbio.jst.go.jp

Cancer Gene Therapy
|August 6, 2005
PubMed

Insights

Antisense oligo DNA (AS-ODN) and small interfering RNA (siRNA) can block malignant cell proliferation. AS-ODN requires a single high dose, while siRNA needs frequent lower doses for effective cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Malignant tumor cells exhibit anchorage-independent proliferation, a key characteristic targeted for cancer therapy.
  • Interfering RNA (RNAi) offers specific and efficient mRNA suppression for therapeutic applications.
  • Antisense oligo DNA (AS-ODN) and small interfering RNA (siRNA) are two RNAi strategies for gene silencing.

Purpose of the Study:

  • To investigate the efficacy of AS-ODN and siRNA in suppressing anchorage-independent proliferation of malignant cells.
  • To compare the treatment regimens and effectiveness of AS-ODN and siRNA for cancer therapy.

Main Methods:

  • Utilized antisense oligo DNA (AS-ODN) and small interfering RNA (siRNA) for gene knockdown.
  • Studied the anchorage-independent proliferation of v-src-transformed rat fibroblasts.
  • Administered single-dose AS-ODN and multiple-dose siRNA treatments.

Main Results:

  • A single 1-microM dose of AS-ODN efficiently suppressed anchorage-independent proliferation.
  • siRNA required treatment with 1 nM every 12 hours to achieve similar suppression.
  • AS-ODN demonstrated molecular stability allowing a simple, high-dose regimen.
  • siRNA was effective at lower concentrations but necessitated more frequent administration.

Conclusions:

  • Both AS-ODN and siRNA are effective in blocking anchorage-independent proliferation of malignant cells.
  • AS-ODN offers a simpler treatment regimen due to its stability, while siRNA requires more frequent application for sustained effect.
  • These findings support the potential of RNAi-based strategies for cancer therapeutics.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...